Episode Details
Back to Episodes
Management of HER2-Altered Non-Small Cell Lung Cancer
Season 1
Published 3 years ago
Description
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.